Congratulations to the RESI South Innovator’s Pitch Challenge Winners! 

By Claire Jeong, Chief Conference Officer, Vice President of Investor Research, Asia BD, LSN

At the inaugural RESI South, we had 43 companies participate in the Innovator’s Pitch Challenge (IPC). These finalist companies pitched to an audience and fielded questions from a panel of investor judges and exhibited a poster showing their technology at the conference. Many of the pitch companies were representative of the seven southern states that were selected by the SE Life Science Investor Coalition and the entities that make up the investor group; Bio Alabama, Bio Florida, Georgia Bio, Life Science Tennessee, NC Life Sciences Organization, SC Bio and Virginia Bio.

Registered RESI attendees (startup executives, early-stage investors, and industry experts), ‘invest’ or vote for their favorite IPC company with RESI cash provided, based on the pitch company’s poster board displayed at RESI’s exhibit hall and their performance in their pitch session.

Life Science Nation is pleased to share the winners who received the most votes during the RESI South. Congratulations to the winners!

1^st Place – SiNON Nano Sciences

At SiNON Nano Sciences we specialize in a patented Carbon Nano Particle (CNP) drug delivery system, specifically designed for targeted treatment of Central Nervous System (CNS) diseases. Our unique release mechanism sets us apart in the market. Our tunable platform delivery system can encapsulate multiple therapeutics, including biologics weighing up to 500kD, and efficiently deliver them across the blood-brain barrier (BBB) to treat various neurological diseases. One of the key advantages of our CNPs is that they only open at the site of the disease, enabling higher concentrated doses while significantly reducing overall toxicity and enhancing therapeutic efficacy. Additionally, our carbon-based nanoparticles go undetected by the immune system.

Cameron Hurlburt, Director of Business Development – West Coast (US), LSN | Dennis Ford, Founder and CEO of Life Science Nation, Creator of the RESI Conference Series | Afreen Allam, CEO, SiNON Nano Sciences | Laura Gunter, President, North Carolina Life Sciences Organization

2^nd Place – Sanguina

Sanguina is a B2B company with a digital health platform and test kits for point of care and home-based diagnostics that measure key biomarkers of wellness and chronic disease.

The first release on the platform, AnemoCheck, is for anemia management and consists of a patented and FDA-cleared home test kit that uses a fingerstick and smartphone app (patent pending and trade secret algorithms) that noninvasively estimates hemoglobin level from a “fingernail selfie”. Anemia is defined as low hemoglobin levels and is a biomarker of disease/treatment progression. The platform is designed to serve clinical trial, point-of-care and home testing markets for those at high risk of anemia via pharmaceutical, supplement, pharmacy and telehealth B2B customers. Specifically, Sanguina focuses on development of tests for biomarkers that are associated with chronic diseases, often associated with treatments, that have traditionally been inaccessible or invasive.

Claire Jeong, Chief Conference Officer, Vice President of Investor Research, Asia BD, LSN | Dennis Ford, Founder and CEO of Life Science Nation, Creator of the RESI Conference Series | Erika Tyburski, CEO, Sanguina | Maria Thacker, President & CEO, Georgia Bio

3^rd Place – Liquet Medical

Liquet Medical is a development stage medical device company. Their first product to market will be the Versus™ Catheter – a localized drug delivery catheter to treat blood clots in the lungs. This device allows for a personalized approach to each patient through real-time biometric data monitoring. It will also speed time-to-treatment and lower hospital costs.

Momo Yamamoto, Investor Research Analyst, LSN | Dennis Ford, Founder and CEO of Life Science Nation, Creator of the RESI Conference Series | John Schindler, CEO & Co-Founder, Liquet Medical | John Newby, CEO, Virginia Bio

If you’re interested in the next upcoming Innovator’s Pitch Challenge, you can apply for the RESI Europe 2024 IPC taking place June 17-19 with a 1-day in-person conference follow by 2-day virtual partnering at Hilton Diagonal Mar Barcelona in Barcelona, Catalonia, Spain. Applications are accepted on a rolling basis, so get your application submitted today!

RESI Europe registration opens at super early bird rates. Register now to save $500 by Friday, April 12.